383 related articles for article (PubMed ID: 33039710)
21. Artificial image objects for classification of breast cancer biomarkers with transcriptome sequencing data and convolutional neural network algorithms.
Chen X; Chen DG; Zhao Z; Balko JM; Chen J
Breast Cancer Res; 2021 Oct; 23(1):96. PubMed ID: 34629099
[TBL] [Abstract][Full Text] [Related]
22. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
[TBL] [Abstract][Full Text] [Related]
23. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
24. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
25. Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation study.
Tolkach Y; Wolgast LM; Damanakis A; Pryalukhin A; Schallenberg S; Hulla W; Eich ML; Schroeder W; Mukhopadhyay A; Fuchs M; Klein S; Bruns C; Büttner R; Gebauer F; Schömig-Markiefka B; Quaas A
Lancet Digit Health; 2023 May; 5(5):e265-e275. PubMed ID: 37100542
[TBL] [Abstract][Full Text] [Related]
26. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
[TBL] [Abstract][Full Text] [Related]
27. A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing.
He B; Sun H; Bao M; Li H; He J; Tian G; Wang B
Sci Rep; 2023 Sep; 13(1):15356. PubMed ID: 37717102
[TBL] [Abstract][Full Text] [Related]
28. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.
Nguyen L; Van Hoeck A; Cuppen E
Nat Commun; 2022 Jul; 13(1):4013. PubMed ID: 35817764
[TBL] [Abstract][Full Text] [Related]
29. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
Posner A; Prall OW; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW
J Pathol; 2023 Jan; 259(1):81-92. PubMed ID: 36287571
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.
Zhang S; He S; Zhu X; Wang Y; Xie Q; Song X; Xu C; Wang W; Xing L; Xia C; Wang Q; Li W; Zhang X; Yu J; Ma S; Shi J; Gu H
Nat Commun; 2023 Sep; 14(1):5686. PubMed ID: 37709764
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
[TBL] [Abstract][Full Text] [Related]
32. Efficient identification of miRNAs for classification of tumor origin.
Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
Oien KA; Dennis JL
Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
[TBL] [Abstract][Full Text] [Related]
34. Progress in refining the clinical management of cancer of unknown primary in the molecular era.
Rassy E; Pavlidis N
Nat Rev Clin Oncol; 2020 Sep; 17(9):541-554. PubMed ID: 32350398
[TBL] [Abstract][Full Text] [Related]
35. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.
Talantov D; Baden J; Jatkoe T; Hahn K; Yu J; Rajpurohit Y; Jiang Y; Choi C; Ross JS; Atkins D; Wang Y; Mazumder A
J Mol Diagn; 2006 Jul; 8(3):320-9. PubMed ID: 16825504
[TBL] [Abstract][Full Text] [Related]
36. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary
Dermawan JK; Rubin BP
Semin Diagn Pathol; 2021 Nov; 38(6):193-198. PubMed ID: 33309276
[TBL] [Abstract][Full Text] [Related]
37. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Moran S; Martínez-Cardús A; Sayols S; Musulén E; Balañá C; Estival-Gonzalez A; Moutinho C; Heyn H; Diaz-Lagares A; de Moura MC; Stella GM; Comoglio PM; Ruiz-Miró M; Matias-Guiu X; Pazo-Cid R; Antón A; Lopez-Lopez R; Soler G; Longo F; Guerra I; Fernandez S; Assenov Y; Plass C; Morales R; Carles J; Bowtell D; Mileshkin L; Sia D; Tothill R; Tabernero J; Llovet JM; Esteller M
Lancet Oncol; 2016 Oct; 17(10):1386-1395. PubMed ID: 27575023
[TBL] [Abstract][Full Text] [Related]
39. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
[TBL] [Abstract][Full Text] [Related]
40. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
